COVID-19大流行期间及之后院外心脏骤停复苏质量的变化
该研究为澳大利亚维多利亚州回顾性队列研究,纳入8,956例接受复苏的成人内科病因院外心脏骤停患者,分为COVID-19前(2019年3月1日至2020年3月15日)、COVID-19期间(2020年3月16日至2022年10月12日)和COVID-19后(2022年10月13日至2023年6月30日)三个时期,采用多变量分位数和逻辑回归分析心肺复苏指标及复苏干预时间的变化。结果显示,与COVID-19前相比,COVID-19期间胸外按压分数(中位差值-0.81个百分点;95%CI -1.07,-0.56)、释放速度(中位差值-5.26毫米/秒;95%CI -9.79,-0.72)和复苏持续时间(中位差值-2.2分钟;95%CI -3.39,-1.05)下降,电击后暂停延长(中位差值0.22秒;95%CI 0.05,0.38),5分钟内给予肾上腺素的风险校正比值比降低(AOR 0.72,95%CI 0.63-0.82),到达后10分钟内插入喉罩的风险校正比值比降低(AOR 0.83,95%CI 0.74-0.94)。除复苏持续时间和喉罩插入时间外,其他指标在COVID-19后时期仍与基线显著不同。结论认为需进一步研究以了解这些变化对院外心脏骤停结局的影响。
要点
- COVID-19期间胸外按压分数较疫情前下降(中位差值-0.81个百分点;95%CI -1.07,-0.56),疫情后仍低于基线。
- COVID-19期间电击后暂停较疫情前延长(中位差值0.22秒;95%CI 0.05,0.38),疫情后仍高于基线。
- COVID-19期间5分钟内给予肾上腺素的风险校正比值比降低(AOR 0.72,95%CI 0.63-0.82),疫情后仍低于基线。
- COVID-19期间到达后10分钟内插入喉罩的风险校正比值比降低(AOR 0.83,95%CI 0.74-0.94),疫情后恢复至基线。
- COVID-19期间释放速度较疫情前下降(中位差值-5.26毫米/秒;95%CI -9.79,-0.72),复苏持续时间缩短(中位差值-2.2分钟;95%CI -3.39,-1.05)。
适用人群与场景
- 澳大利亚维多利亚州成人院外心脏骤停患者,内科病因,且接受了尝试性复苏。
- 研究分为三个时期:COVID-19前(2019年3月1日至2020年3月15日)、COVID-19期间(2020年3月16日至2022年10月12日)和COVID-19后(2022年10月13日至2023年6月30日)。
研究设计与关键结果
- 研究类型为回顾性队列研究,纳入8,956例患者(COVID-19前2,389例,COVID-19期间4,935例,COVID-19后1,632例)。
- 与COVID-19前相比,COVID-19期间胸外按压分数中位差值-0.81个百分点(95%CI -1.07,-0.56),释放速度中位差值-5.26毫米/秒(95%CI -9.79,-0.72),复苏持续时间中位差值-2.2分钟(95%CI -3.39,-1.05)。
- COVID-19期间电击后暂停较COVID-19前延长(中位差值0.22秒;95%CI 0.05,0.38)。
- COVID-19期间5分钟内给予肾上腺素的风险校正比值比降低(AOR 0.72,95%CI 0.63-0.82)。
- COVID-19期间到达后10分钟内插入喉罩的风险校正比值比降低(AOR 0.83,95%CI 0.74-0.94)。
- 除复苏持续时间和喉罩插入时间外,其他指标在COVID-19后时期仍与基线显著不同。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 该研究提示COVID-19期间个人防护装备要求可能与心肺复苏质量指标下降和复苏干预延迟相关,部分指标在疫情后仍低于疫情前水平。
- 作者认为需要进一步研究以了解这些变化对院外心脏骤停结局的影响。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: The impact of personal protective equipment (PPE) on resuscitation quality is largely unknown. We sought to examine the effect of PPE requirements on CPR quality and resuscitation interventions during the COVID-19 pandemic in Victoria, Australia.
METHODS: We performed a retrospective cohort study of adult OHCA patients of medical aetiology who received attempted resuscitation. The study consisted of three periods; a pre-COVID-19 period (1st March 2019 to 15th March 2020), the COVID-19 period (16th March 2020 to 12th October 2022) and a post-COVID-19 period (13th October 2022 to 30th June 2023). Multivariable quantile and logistic regression were used to examine changes in CPR metrics and time to resuscitation interventions across the three periods.
RESULTS: We included 8,956 patients (2,389 pre-COVID-19, 4,935 during COVID-19 and 1,632 post-COVID-19). A number of CPR quality metrics deteriorated during the COVID-19 period compared to the pre-COVID-19 period, including: chest compression fraction (median difference [MD] -0.81 percentage points; 95% CI -1.07,-0.56), release velocity (MD -5.26 mm per second; 95% CI -9.79, -0.72) and resuscitation duration (MD -2.2 min; 95% CI -3.39, -1.05). The COVID-19 period was also associated with longer post-shock pauses (MD 0.22 s; 95% CI 0.05, 0.38), and a reduction in the risk-adjusted odds of receiving adrenaline administration within 5 mins (AOR 0.72, 95% CI 0.63 - 0.82) and laryngeal mask insertion within 10 mins of arrival (AOR 0.83, 95% CI 0.74 - 0.94). These factors, with the exception of resuscitation duration and time to larygeal mask insertion, remained significantly different from baseline for the post-COVID-19 period.
CONCLUSION: Several CPR quality metrics declined during the COVID-19 period and some remain below pre-pandemic levels. Further research is needed to understand these impacts on OHCA outcomes.
参考来源
- Kennedy C, Nehme E, Anderson D, et al. Changes in out-of-hospital cardiac arrest resuscitation quality during and after the COVID-19 pandemic. Resuscitation. 2024. PMID: 39447960. doi:10.1016/j.resuscitation.2024.110419
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。